RecruitingNCT07125885

Gongji Pregnancy Endorine Cohort Study

Serological, Metabolomic, and Genomic Studies of Endocrine Disorders in Pregnancy

Sponsor

Shanghai General Hospital, China

Enrollment

3,000 participants

Start Date

May 5, 2023

Study Type

OBSERVATIONAL

Conditions

Gestatiaonl Diabetes Mellitus Thyroid Disease Pregnancy Hyperglycemia in Pregnant Diabetic Patients

Summary

To explore the relationship between genetic factors, lifestyle, and drug interventions and the occurrence, development, adverse pregnancy outcomes, and postpartum maternal-infant outcomes of gestational endocrine diseases.

Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with gestatiaonl diabetes mellitus, hyperglycemia in pregnant diabetic patients, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Shanghai General Hospital, China

Shanghai, Shanghai Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07125885

Related Trials

Shanghai Clinical Cohort of Hyperglycemia in Pregnancy

NCT071619471 location

Prenatal Ultrasonographic Assessment of Fetal Thyroid in Patients With Thyroid Pathology

NCT067888212 locations